期刊文献+

血管紧张素原基因多态性与深静脉血栓的相关性研究 被引量:4

Study on the association between polymorphisms in angiotensinogen gene and deep venous thrombosis
原文传递
导出
摘要 目的探讨血管紧张素原(angiotensinogen,ACT)基因-6G/A、-20A/C、T174M 3种基因型多态在深静脉血栓发病中的意义。方法应用PCR-限制性片段长度多态性方法对103例深静脉血栓患者和250名健康对照者进行AGT-6G/A、-20A/C、T174M基因多态性的检测,并进行基因型及等位基因频率和单倍型分析。结果-6G/AGA基因型在深静脉血栓组中的分布频率(60.2%)明显高于对照组(39.6%),经x^2检验差异具有统计学意义(P〈0.05)。单倍型分析显示病例组中-20A/-6G/174T单倍型频率高于对照组(P〈0.05)。-20A/-6A/174T单倍型频率低于对照组(P〈0.05)。-20A/C、T174M基因型在两组的分布频率差异无统计学意义。结论AGT-6G/A多态性中,GA基因型可能会增加深静脉血栓的发生。-20A/-6G/174T单倍型可能是静脉血栓的危险因素,-20A/-6A/174T单倍型可能是静脉血栓的保护因素。 Objective To investigate the association of polymorphism of angiotensinogen (AGT) - 6G/A, - 20A/C and T174M with the development of deep venous thrombosis. Methods One hundred and three patients with deep venous thrombosis (DVT group) and 250 healthy subjects (control group) were recruited in the study. The polymorphisms of angioteusinogen - 6G/A, - 20A/C and T174M were detected by PCR-RFLP. Retmlts The prevalence of GA genotype of - 6G/A in the DVT group was significantly higher than that in the control group ( P 〈 0.05 ) and the prevalence of -20A/- 6A/174T haplotype in the DVT group was lower than that in the control group( P 〈 0.05). There were no significant differences in the prevalence of - 20A/C and T174M polymorphism. Conclusion The GA genotypes of -6G/A may increase the development of DVT and the - 20A/- 6G/174T haplotype may be a risk factor of DVT. However, the - 20A/- 6A/174T haplotype may be a protective factor of DVT.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2008年第3期300-303,共4页 Chinese Journal of Medical Genetics
基金 河南省高校杰出人才创新工程基金(2005KYCX02) 河南省杰出青年科学基金(0612001300) 河南省攻关项目(0624410049)
关键词 深静脉血栓 血管紧张素原 遗传多态性 单倍型 deep venous thrombosis angioteusinogen genetic polymorphism haplotype
  • 相关文献

参考文献17

  • 1叶琼,吴可贵,谢良地,曾开淇,林经安,林从容.血管紧张素原及血管紧张素转化酶基因多态性与高血压之间的关系[J].中华医学遗传学杂志,2000,17(1):28-31. 被引量:32
  • 2Ishigami T, Umemura S, Tamura K, et ol. Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension, 1997,30: 1325-1330.
  • 3Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C . PNAS , 1993,90: 1004-1008.
  • 4Bertina RaM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994, 369 : 64-67.
  • 5Engbersen AMT, Franken DG, Boers GHJ, et al. Thermolabile 5, 10- methy lenetetrahydrofolate reductase as a cause of mild hyperhomocystei nemia . Am J Hum Genet,1995,56:142-150.
  • 6Poort SR, Rosendaal FR, Reitsma PH, et al.A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996,88 : 3698-3703.
  • 7Labinjoh C, Newby DE, Dawson P, et al. Fibrinolytic actions of intra-arterial angiotensin Ⅱ and bradykinin in vivo in man. Cardiovasc Res, 2000,47:707-714.
  • 8Nngata K,lshibashi T,Sakamoto T, et al. Effects of blockade of the reninangiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes. Hypertens, 2001,19:775-783.
  • 9孔祥琴.血管紧张素Ⅳ与血栓[J].心血管病学进展,2001,22(6):376-378. 被引量:1
  • 10何美霞.肾素-血管紧张素系统的促栓作用[J].国外医学(输血及血液学分册),2003,26(2):108-110. 被引量:1

二级参考文献11

共引文献49

同被引文献56

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部